SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-096250
Filing Date
2022-08-31
Accepted
2022-08-31 06:40:28
Documents
14
Period of Report
2022-08-31
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2224733d1_8k.htm   iXBRL 8-K 25083
2 EXHIBIT 99.1 tm2224733d1_ex99-1.htm EX-99.1 20925
6 GRAPHIC tm2224733d1_ex99-1img001.jpg GRAPHIC 11564
  Complete submission text file 0001104659-22-096250.txt   234708

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imgn-20220831.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imgn-20220831_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imgn-20220831_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2224733d1_8k_htm.xml XML 3464
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 221216241
SIC: 2834 Pharmaceutical Preparations